Form 4 for ABT Abbott Laboratories
Accepted 2021-12-08 00:00:00 ET · period of report 2021-12-06 · accession 0001415889-21-005788 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-08 | 2021-12-06 | ABT | Wainer Andrea F | EVP | S - Sale+OE | $132.50 | -4,500 | 49.8K | -8% | -$596.2K |
| D | 2021-12-08 | 2021-12-06 | ABT | Wainer Andrea F | EVP | M - OptEx | $47.00 | +4,500 | 54.3K | +9% | +$211.5K |
| D | 2021-12-08 | 2021-12-06 | ABT | Wainer Andrea F | EVP | M - OptEx | $0.00 | -4,500 | 28.7K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2021-12-06 | S | D | 4,500 | $132.50 | 49,782 | D | — | — | |
| 2 | Common | Common shares without par value | 2021-12-06 | M | A | 4,500 | $47.00 | 54,282 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2021-12-06 | M | D | 4,500 | $0.00 | 28,726 | D | $47.00 · 2018-02-20 to 2025-02-19 | 4,500 Common Shares | (F1) Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |